Glucose Meters in California

Fresh Test, LLC is a Class II medical device manufacturer specializing in diagnostic glucose beverages for diabetes and gestational diabetes mellitus screening. The company produces a line of natural glucose tolerance test drinks available in 50g, 75g, and 100g formulations, offered in three formats: ready-to-drink bottles, powder-in-a-bottle, and pouches. All products are formulated with three simple ingredients (purified water, non-GMO glucose, organic lemon, and organic mint), free from artificial additives, dyes, and preservatives. The beverages are Non-GMO certified, gluten-free, and packaged in BPA-free containers. Fresh Test products are laboratory-tested for exact glucose equivalency and compliance, with negligible amounts of fructose, sucrose, and fiber. The company maintains a 30-month shelf life and supplies wholesale packaging in 10-unit and 30-unit boxes. Fresh Test holds FDA clearance (3017544399) and operates under ISO 17025 third-party laboratory certification. The company is trusted by leading hospital systems and clinical laboratories nationwide, including HCA, Intermountain Health, Kaiser Permanente, and Medline Industries. Fresh Test offers direct-to-consumer and healthcare provider distribution channels, with clinical resources and a medical advisory board comprising physicians and certified diabetes educators.

RENPHO is a global consumer wellness technology brand founded in 2016, headquartered in California with international offices. The company specializes in connected smart health devices and wearables that enable individuals to track and optimize personal health metrics through advanced body composition analysis, vital sign monitoring, and recovery/wellness solutions. Core product categories include smart body composition scales (MorphoScan series using DF-BIA technology), wearable health tracking devices (LYNX smart ring, smart tape measures), eye and foot massage systems, therapeutic massage guns with temperature control, air compression recovery boots, and beauty/aesthetic devices (LED light therapy masks). All devices integrate with RENPHO's free Health App ecosystem, which serves 20M+ users globally with data analytics, goal tracking, and community features. Products are FSA/HSA eligible and clinically validated, with distribution across 100+ countries. The brand targets health-conscious consumers, fitness enthusiasts, and individuals managing chronic health conditions through accessible, app-connected health monitoring technology.

Acro Biotech, Inc. is a medical diagnostics manufacturer based in Montclair, California, specializing in point-of-care and clinical laboratory testing solutions. The company develops and distributes a diverse portfolio of diagnostic analyzers and rapid testing systems across multiple therapeutic and clinical domains. Product lines include respiratory infection rapid tests (COVID-19 and other respiratory panels, though COVID tests are not FDA-cleared for US distribution), drugs of abuse screening tests, cardiac biomarker assays, urine analyzers, fluorescence immunoassay analyzers, and multiparameter handheld meters for hemoglobin, cholesterol, uric acid, and glucose testing. The company also offers solutions for women's health, infectious disease serology, tumor markers, and veterinary diagnostics. Key analyzer platforms include the ATR-ACO300 urine analyzer, AFR-600 fluorescence immunoassay system (Apoti), AHR-100 multiparameter meter for hemoglobin/cholesterol/uric acid/glucose, and LF Reader systems. The company serves clinical laboratories, point-of-care testing facilities, and veterinary markets with rapid testing and automated laboratory equipment. No specific FDA 510(k) clearances, ISO certifications, or CE Mark designations are stated on the website. Manufacturing capabilities and regulatory status for products marketed outside the US are not detailed in available content.

Dexcom, Inc. is a leader in continuous glucose monitoring (CGM) systems and glucose biosensing technology, founded in 1999 and headquartered in San Diego, California. The company develops real-time glucose sensing devices that transmit glucose readings directly to smartphones and receivers, enabling people with diabetes to monitor their blood glucose levels continuously and make informed treatment decisions. Dexcom's primary product line includes the Dexcom G7 CGM System and the Dexcom G7 15 Day sensor, designed for adults 18+ with all types of diabetes. The G7 offers best-in-class accuracy and an extended 15-day wear period, with approximately 74% of sensors lasting the full duration. The company also offers Stelo Glucose Biosensor, an over-the-counter (OTC) integrated CGM intended for people 18+ not on insulin, including those with prediabetes or seeking general wellness optimization. Stelo requires no prescription, no fingersticks, and delivers personal glucose insights to users' phones. Dexcom's ecosystem includes connectivity with multiple smart devices and partner integrations to reduce the burden of diabetes management. The company serves patients across multiple insurance channels including commercial, Medicare Advantage, Medicare, Medicaid, VA Health Care, and Kaiser, as well as uninsured/cash-pay patients. Dexcom maintains FDA 510(k) clearance and regulatory compliance for its medical devices and supports healthcare providers through a dedicated provider portal. Manufacturing and distribution capabilities include pharmacy and medical supplier channels.

Glooko is a digital health platform specializing in diabetes management and glycemic control. The company operates two primary product lines: the outpatient Glooko Diabetes Management Platform and the inpatient EndoTool Glucose Management System (acquired via Monarch Medical Technologies). The outpatient platform integrates data from over 200 diabetes and health monitoring devices, providing seamless connectivity with continuous glucose monitors (CGMs), blood glucose meters, and wearables. It enables remote patient monitoring, population health management, and secure remote collaboration between patients and care teams through the Glooko Mobile App and clinic dashboard. EndoTool is a patient-specific insulin dosing system designed for hospital inpatient glycemic management, with clinical data showing virtual elimination of severe hypoglycemia. Glooko serves 8,000+ clinics across 30+ countries, providing actionable insights to streamline clinical workflows and improve diabetes outcomes. Clinical evidence demonstrates 18% reduction in average blood glucose within three months and sustained HbA1c improvements. The company maintains robust security and privacy compliance including HITRUST, HIPAA, SOC 2 Type II, ISO 27001, and GDPR certifications, ensuring enterprise-grade data protection for patient health information. Glooko's platform is built on device connectivity standards and interoperability principles to eliminate fragmented data across healthcare systems. The company targets hospitals, health systems, clinics, and individual patients requiring comprehensive diabetes data management and remote monitoring capabilities.

i-SENS USA, Inc. is a US-based distributor and retailer of blood glucose monitoring systems and related diabetes management devices. The company specializes in the CareSens product line, offering multiple glucose meter models including CareSens N, CareSens N Plus (with Bluetooth connectivity), and CareSens N Feliz variants. These meters are designed for diabetic health management, metabolic monitoring, and gestational diabetes screening. The company positions itself as a consumer-direct supplier of glucose monitoring consumables and devices, with educational content on fasting blood sugar, ketone measurement, Glucose Ketone Index (GKI), and dietary management for metabolic health. Products are sold via direct e-commerce with starter kits bundled with test strips. The company serves self-monitoring patients, including those managing prediabetes, Type 2 diabetes, and gestational diabetes mellitus. Regulatory status and certifications are not explicitly stated on the website.

Movano Health is a wearable medical device company specializing in personalized health monitoring technology. The company develops smart rings and wearable sensors featuring patented radio frequency (RF) technology for non-invasive, cuffless vital sign monitoring including blood pressure, glucose levels, and pulse oximetry. The Evie Ring is designed for women's health with trend tracking and Apple Health integration, while the EvieMED Ring is FDA 510(k)-cleared for clinical-grade pulse oximetry. Movano's proprietary RF chip enables miniaturized, accurate biometric sensing without traditional cuffs or continuous calibration. The company advances clinical validation through partnerships with health researchers and ongoing FDA-regulated clinical studies to expand approved indications for glucose and blood pressure monitoring.

Cliawaived, Inc. is a CLIA-waived medical testing and diagnostic supplies distributor serving clinical labs, physician offices, and home-use markets. The company supplies a broad range of point-of-care (POC) testing products including rapid drug screening tests (drug test cards and cups), infectious disease diagnostics (COVID-19, flu, RSV, mono, strep testing), STD/sexual health testing kits, urinalysis consumables, women's health tests, and general medical supplies. Product portfolio includes analyzers and meter devices (glucose monitors and similar POC analyzers), distributed under partnerships with established manufacturers such as Quidel. The company operates an e-commerce platform enabling B2B procurement of CLIA-waived test kits and supplies for clinical settings and direct-to-consumer home testing products. As a distributor of CLIA-waived diagnostics, Cliawaived serves urgent care centers, physician offices, occupational health programs (workplace drug screening), clinical laboratories, and patients seeking over-the-counter diagnostic testing. All products are CLIA-waived, meeting regulatory thresholds for simple test methodology and low clinical risk. The company maintains inventory of consumables and point-of-care instrumentation to support rapid deployment and same/next-day fulfillment for high-volume testing operations.

Signos is an AI-powered metabolic health platform that combines continuous glucose monitoring (CGM) with personalized weight management guidance for non-diabetic and metabolically-conscious consumers. The platform integrates Dexcom G7 CGM sensors with a proprietary mobile application that uses machine learning to analyze glucose patterns and predict individual metabolic responses to food, exercise, sleep, and stress. Members receive real-time glucose tracking, personalized eating and movement recommendations, registered dietitian support, and weekly metabolic reporting. The service is FDA-cleared and HSA/FSA-eligible, offered through direct consumer channels and employer-sponsored wellness programs. Clinical outcomes show 86% of members report success in their first month, with significant weight loss and improved metabolic stability.

ForaCare Inc. is a healthcare technology company specializing in chronic disease management through integrated medical devices and telehealth software. The company designs and manufactures blood glucose monitors, blood pressure monitors, pulse oximeters, nebulizers, wireless weight scales, and Bluetooth thermometers for diabetes, hypertension, COPD, and chronic heart failure management. All devices connect via cellular or Bluetooth to the proprietary FORA® 24/7 HealthView Telehealth System, a HIPAA-compliant cloud platform that enables real-time remote patient monitoring and physician access to patient data. ForaCare also offers iFORA mobile applications available on iOS and Google Play for patient engagement and chronic disease self-management. The company manufactures and designs products with an emphasis on accuracy, ease of use, and clinical validation. Primary markets include remote patient monitoring programs for chronic disease management across diabetes care, hypertension management, respiratory care, and weight management. The FORA 24/7 HealthView System serves as the central integration hub connecting all wireless medical devices to a telehealth gateway for comprehensive remote monitoring. ForaCare operates with a global customer base and maintains design and manufacturing capabilities.

i-SENS is a global biotechnology company headquartered in South Korea and operating in over 110 countries, including the United States and Europe. The company is the market leader in Korea's blood glucose monitoring device market and specializes in blood glucose management systems, continuous glucose monitoring (CGM) systems, in vitro diagnostics (IVD), and veterinary diagnostic solutions. i-SENS manufactures the CareSens line of self-monitoring blood glucose systems, which meets ISO 15197:2013 accuracy standards for hematocrit and interference criteria. The CareSens Air continuous glucose monitoring system is the first domestically produced CGM in Korea with CE certification, providing real-time glucose data and trend analysis for diabetes management. The company's IVD System leverages whole blood-based diagnostic technology for point-of-care testing applications. i-SENS operates with an annual production capacity of 2.1 billion blood glucose test strips, supporting millions of patients globally. The company maintains regulatory compliance with FDA and CE certification standards. Recent partnerships include a transformational collaboration with LifeScan to launch the OneTouch® Continuous Glucose Monitoring System, leveraging i-SENS technology. The company serves healthcare systems, diabetes management clinics, point-of-care diagnostic facilities, and veterinary care providers. i-SENS is committed to advancing diabetes care innovation and expanding access to glucose monitoring solutions worldwide.

Gojji is a chronic disease management platform that delivers remote monitoring and personalized care support for patients with diabetes, hypertension, high cholesterol, and related conditions. The company operates a whole-person care and population health program aligned with payors and primary care providers to bridge gaps between clinical visits. Gojji's service model includes real-time glucose monitoring via personal meters, telephonic care coordination, dietary guidance, medication management, and continuous health tracking accessible through a patient portal. The platform integrates with healthcare systems and supports multiple chronic disease prevention programs including diabetes prevention, obesity/weight management, and asthma/COPD management. Gojji serves community health centers, federally qualified health centers (FQHCs), and health plans across California, with particular strength in Medi-Cal populations. The company provides multilingual support (12+ languages) and operates business hours Monday–Friday, 8:00 AM–6:00 PM. Patient testimonials emphasize improved blood sugar control and empowered self-management through frequent monitoring and personalized coaching. Gojji's clinical model emphasizes individualized experiences, real-time data visibility, and collaborative care between patients, primary care physicians, specialists, and payors to shift populations toward improved health outcomes.

AOA Medical is a wholesale medical supplies and equipment distributor serving hospitals, clinics, senior centers, and assisted living facilities. The company supplies a comprehensive catalog of health monitoring devices, postoperative medical essentials, mobility aids, and wound care products sourced from leading manufacturers. Primary product lines include blood glucose monitoring systems, blood pressure monitors, orthopedic support devices (inflatable walker boots, gait belts), and postoperative wound management supplies including silicone scar tape. Beyond equipment distribution, AOA Medical offers corporate wellness programs and on-site health monitoring services to businesses of all sizes, including chair massage events, yoga and meditation sessions, and employee health screening services (blood pressure, glucose, and pulse monitoring). The company positions itself as a trusted partner for healthcare institutions and businesses seeking to improve patient outcomes and employee well-being. Services include wellness program consultation, custom program development, and on-site delivery of wellness initiatives. Target markets span institutional healthcare providers and corporate employers seeking proactive health management solutions.

Altek Biotechnology Corporation is a leading digital imaging technology contract manufacturer (CDMO) specializing in OEM and ODM services for medical device brand companies. The company holds market-leading positions as the worldwide No. 1 BGM (blood glucose meter) CDMO and the worldwide No. 1 single-use endoscope CDMO. Core product categories include glucose meters, single-use (disposable) endoscopes, and intelligent insulin delivery systems. Altek offers comprehensive capabilities spanning the full product development lifecycle: concept development, R&D engineering, prototyping, product development, manufacturing, quality assurance, and process automation. The company specializes in miniaturization and digital imaging technologies, enabling manufacturers to bring innovative point-of-care and home-use diagnostic devices to market. With established long-term partnerships with tier-one global medical brands, Altek provides turnkey solutions from initial concept through mass production, emphasizing superior manufacturing processes, regulatory compliance, and product optimization. The company leverages expertise in automation and quality assurance to explore hidden compliance risks beyond baseline conformity requirements.

Tidepool is a digital health platform that aggregates and visualizes diabetes management data from multiple device manufacturers into a unified, cloud-based system. The company provides software solutions for patients, caregivers, and healthcare providers to securely upload, access, and analyze continuous glucose monitoring (CGM) data, insulin pump data, and blood glucose meter readings from devices manufactured by Medtronic, Tandem, Omnipod, Dexcom, Abbott FreeStyle Libre, and numerous other diabetes device makers. Tidepool offers three primary software products: Tidepool Uploader (desktop application for data synchronization), Tidepool Mobile (patient-facing app for device pairing and data review), and Tidepool Data Platform with a Population Health Dashboard for healthcare provider insights. The company also develops Tidepool Loop, a closed-loop automated insulin delivery system derived from the open-source Loop community, distributed commercially by Sequel Medical Technologies as twiist Loop. Tidepool serves patients managing type 1 and type 2 diabetes, healthcare providers including endocrinologists and primary care physicians, telemedicine platforms, and diabetes researchers. The platform integrates real-time data from 40+ compatible devices and emphasizes accessible, actionable insights to improve glycemic control and reduce diabetes management burden. Tidepool supports HIPAA-compliant data sharing and serves the US market with focus on accessibility and interoperability across the diabetes device ecosystem.

BiometerPlus USA, Inc. manufactures electrochemical biosensor-based handheld diagnostic meters for home and clinical self-testing. The company's primary product line uses advanced electrochemical technology to measure glucose, total cholesterol, HDL, LDL, and triglyceride levels from capillary blood samples (10 µL). Devices feature built-in strip identification, battery-powered operation (2 AAA batteries), wireless connectivity capability, and results display within 30 seconds. The meters are designed for ease of use with minimal, intuitive design incorporating LED indicators, setup buttons, and dedicated testing strip slots. Products support self-management applications in chronic disease monitoring, particularly diabetes and lipid panel testing in home care settings. The company emphasizes energy efficiency, superior industrial design, and high compatibility across testing strip types. Target markets include individual consumers, home healthcare providers, and clinical settings requiring point-of-care diagnostics.

ACON Laboratories, Inc. is a US FDA-registered global medical device manufacturer specializing in point-of-care testing (POCT) and immunoassay products. Headquartered in San Diego, California, the company develops and manufactures diagnostic solutions across four primary product lines: Point of Care, Immunoassays, Molecular Diagnostics, and Animal Health. Products serve hospitals, clinical laboratories, physician offices, blood banks, pharmacies, and veterinary clinics worldwide. The On Call® Blood Glucose Meter Family is designed for glucose monitoring and diabetes management. Mission® brand includes urine reagent test strips, urine analyzers, and handheld devices for cholesterol, coagulation, and hemoglobin measurement. HealthyMe® provides urinary tract infection (UTI) detection reagent strips. Flow flex® is the newest lateral flow rapid testing brand, offering multiplexed home tests including the recently FDA 510(k)-cleared Flow flex® Plus RSV + Flu A/B + COVID multiplex rapid antigen test for ages 6 months and up. The company's ACON brand offers lateral flow rapid tests for pregnancy, cancer markers, and infectious disease screening, including SARS-CoV-2 antibody and antigen tests. Distinct® provides pregnancy rapid tests using qualitative chromatographic immunoassays. Foresight® offers allergen immunoblot testing for 30 allergens on a single strip. Promotor® provides nucleic acid extraction systems and PCR quantitative test kits for HBV, HCV, HPV 16/18, HPV genotyping, tuberculosis, and HLA-B27. CentriVet® serves veterinary diagnostics with dual ketone/glucose meters and urine reagent strips. ACON maintains US FDA registration, provides contract manufacturing and OEM services, and holds multiple FDA 510(k) clearances for its diagnostic products.

Thirdwayv is an IoT connectivity and cybersecurity software company specializing in secure, connected medical devices and healthcare applications. The company provides end-to-end security solutions—from hardware root of trust through cloud infrastructure—for safety-critical IoT deployments in consumer medical devices, connected hospitals, home healthcare, electrical stimulation and drug delivery systems, and biometric monitoring. Core product lines include AppAuth™ (device and customer authentication, remote attestation), SecureConnectivity™ (application-layer encryption across Bluetooth, NFC, LTE, Ethernet), SeamlessConnect™ (seamless device-to-gateway connectivity), and RecordAuth™ (blockchain-based data authenticity for supply chains). Thirdwayv holds FDA clearances enabling partners to meet FDA cybersecurity guidelines for medical devices and has demonstrated expertise in connected diabetes management, pacemakers, nerve stimulators, defibrillators, insulin pumps, thermometers, blood pressure monitors, glucose meters, and pulse oximeters. The company also serves connected car (OTA firmware updates, infotainment security, smartphone keyless entry) and asset-tracking markets (cold chain, surgical implant track-and-trace, hospital inventory management, retail item tracking). Leadership includes executives from Motorola, Broadcom, and GE; the advisory board includes former Qualcomm, Google, BlackBerry, and FDA officials. Thirdwayv positions itself as a "nucleus of trust" for IoT ecosystems, emphasizing security-by-design from the semiconductor level upward.

Metene Limited is a global homecare and personal medical device manufacturer specializing in blood glucose monitoring systems and vital signs monitoring devices. The company claims to be the world's No. 1 blood glucose monitor brand, with products sold in 58 countries and over 60 million units distributed worldwide. Metene's primary product line comprises blood glucose meters (TD-4116 and AGM-513S models), compatible test strips, and lancing devices designed for diabetics, elderly patients, pregnant women, and individuals at risk of diabetes. Key product features include rapid 5–7 second readings, minimal blood sample requirements (0.5–0.7 μL), no-coding convenience, data storage, and reminder alarms. The company also manufactures fingertip pulse oximeters (SpO2 monitors) and no-touch thermometers. Metene devices utilize advanced biosensor technologies including Glucose Dehydrogenase (FAD-GDH) enzymes and 99.99% gold electrodes to minimize interference and temperature/humidity deviation. Products are marketed as suitable for home and consumer use rather than clinical/hospital settings. The company operates a direct-to-consumer e-commerce platform (metene.com) with educational content on diabetes management and blood glucose monitoring. While the site emphasizes consumer accessibility and ease of use, specific regulatory certifications (FDA 510(k), CE marking, ISO 13485) are not explicitly mentioned in the fetched content. Manufacturing location and quality certifications remain undisclosed on the primary website.

iHealth Labs Inc is a leader in consumer and clinical-grade home health monitoring devices founded in 2010. The company manufactures and distributes wireless vitals monitoring systems, rapid diagnostic tests, and telehealth-integrated solutions for patient self-management and remote patient monitoring (RPM). Product portfolio includes blood pressure monitors (Neo, Track Pro, 550BT models), wireless glucose monitors (Gluco+ system), pulse oximeters (Air Pulse), digital and infrared thermometers (PT1, PT3, PT5), and rapid diagnostic tests for COVID-19, influenza A/B detection. iHealth devices feature Bluetooth connectivity, cloud-based app integration (iHealth MyVitals), and clinical validation. The company holds FDA authorization for rapid test kits and has supplied millions of COVID-19 tests to the U.S. federal government. iHealth also operates iHealth Unified Care, a remote patient monitoring platform enabling Chronic Care Management (CCM) and RPM billing for healthcare providers. Products are FSA/HSA-eligible and sold direct-to-consumer and through healthcare systems. The company serves homecare, chronic disease management, and provider-based RPM markets with emphasis on ease of use, wireless connectivity, and integration with EHR/digital health workflows.